• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-A12B filed by NorthView Acquisition Corporation

    7/11/25 12:45:10 PM ET
    $NVAC
    Medical/Dental Instruments
    Health Care
    Get the next $NVAC alert in real time by email
    8-A12B 1 ea0248717-8a12b_profusa.htm FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

     

     

    U.S. SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549 

     

    FORM 8-A

     

    FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

    PURSUANT TO SECTION 12(b) OR 12(g) OF THE

    SECURITIES EXCHANGE ACT OF 1934

     

    Profusa, Inc.

    (Exact name of registrant as specified in its charter)

     

    Delaware   86-3437271
    (State or other jurisdiction
    of incorporation or organization)
      (I.R.S. Employer
    Identification No.)
         

    626 Bancroft Way, Suite A

    Berkeley, CA

      94710
    (Address of principal executive offices)   (Zip Code)

     

    Securities to be registered pursuant to Section 12(b) of the Act:

     

    Title of each class
    to be so registered
      Name of each exchange on which
    each class is to be registered
    Shares of common stock, $0.0001 par value   The Nasdaq Stock Market LLC

     

    If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), please check the following box. ☒

     

    If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), please check the following box. ☐

     

    If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ☐

     

    Securities Act registration statement or Regulation A offering statement file number to which this form relates: 333-269417 (if applicable)

     

    Securities to be registered pursuant to Section 12(g) of the Act:

     

    N/A
    (Title of Class)

     

     

     

     

     

     

    EXPLANATORY NOTE

     

    This Form 8-A filed by Profusa, Inc., a Delaware corporation (formerly known as NorthView Acquisition Corporation, the “Registrant”), replaces the Form 8-A that was filed by NorthView Acquisition Corporation on June 18, 2025. In connection with the consummation of a business combination between the Registrant and Profusa, Inc., a California corporation, on July 11, 2025, the Registrant changed its name from “NorthView Acquisition Corporation” to “Profusa, Inc.”

     

    1

     

     

    Item 1. Description of Registrant’s Securities to be Registered.

     

    The securities to be registered hereby are the common stock, par value $0.0001 per share, of Profusa, Inc. (the “Registrant”). The description of the common stock set forth under the heading “Description of Securities” in the Registrant’s prospectus forming a part of its Registration Statement on Form S-4 (File No. 333-269417), originally filed with the U.S. Securities and Exchange Commission on January 25, 2023, as thereafter amended and supplemented from time to time (the “Registration Statement”), to which this Form 8-A relates, is incorporated by reference herein. Any form of prospectus or prospectus supplement to the Registration Statement that includes such descriptions and that is subsequently filed is hereby also incorporated by reference herein.

     

    Item 2. Exhibits.

     

    Under the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The Nasdaq Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

     

    2

     

     

    SIGNATURE

     

    Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

     

      Very truly yours,
       
      Profusa, Inc.
         
      By:  /s/ Fred Knechtel
        Fred Knechtel
        Chief Financial Officer

     

    Dated: July 11, 2025

     

    3

     

    Get the next $NVAC alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NVAC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $NVAC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Asarpota Rajesh

    3 - Profusa, Inc. (0001859807) (Issuer)

    7/22/25 12:41:43 PM ET
    $NVAC
    Medical/Dental Instruments
    Health Care

    New insider Hwang Ben Chung-Bin claimed ownership of 844,228 shares (SEC Form 3)

    3 - Profusa, Inc. (0001859807) (Issuer)

    7/21/25 6:42:26 PM ET
    $NVAC
    Medical/Dental Instruments
    Health Care

    $NVAC
    SEC Filings

    View All

    NorthView Acquisition Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Change in Shell Company Status, Other Events

    8-K - Profusa, Inc. (0001859807) (Filer)

    7/18/25 4:23:40 PM ET
    $NVAC
    Medical/Dental Instruments
    Health Care

    SEC Form DEF 14C filed by NorthView Acquisition Corporation

    DEF 14C - NorthView Acquisition Corp (0001859807) (Filer)

    7/14/25 6:52:12 PM ET
    $NVAC
    Medical/Dental Instruments
    Health Care

    SEC Form CERT filed by NorthView Acquisition Corporation

    CERT - NorthView Acquisition Corp (0001859807) (Filer)

    7/11/25 1:49:25 PM ET
    $NVAC
    Medical/Dental Instruments
    Health Care

    $NVAC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    NorthView Acquisition Corporation Announces Receipt of Notice from Nasdaq Regarding Failure to Complete Initial Business Combination

    New York, NY, Dec. 26, 2024 (GLOBE NEWSWIRE) -- NorthView Acquisition Corporation (NASDAQ:NVAC) (the "Company") announced that it has received a notice (the "Notice") from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") indicating that (i) the Staff has determined that the Company's securities will be delisted from The Nasdaq Stock Market; (ii) trading of the Company's Common Stock, Rights, and Warrants will be suspended at the opening of business on December 27, 2024; and (iii) a Form 25-NSE will be filed with the Securities and Exchange Commission (the "SEC"), which will remove the Company's securities from listing on The Nasdaq Stock Market. Pursuant to

    12/26/24 4:30:00 PM ET
    $NVAC
    Medical/Dental Instruments
    Health Care

    NorthView Acquisition Corporation Announces Receipt of Notice from Nasdaq Regarding Filing of Quarterly Report on Form 10-Q

    New York, NY, Dec. 11, 2024 (GLOBE NEWSWIRE) -- NorthView Acquisition Corporation. (NASDAQ:NVAC) (the "Company") announced that it has received a notice (the "Notice") from The Nasdaq Stock Market LLC ("Nasdaq") stating that because the Company has not yet filed its Form 10-Q for the period ended September 30, 2024, the Company is no longer in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the "SEC"). This notification has no immediate effect on the listing of the Company's shares on Nasdaq. However, if the Company fails to timely regain compliance with the

    12/11/24 6:30:00 PM ET
    $NVAC
    Medical/Dental Instruments
    Health Care

    NorthView Acquisition Corporation Announces Exception Granted by Nasdaq to Permit to The Company to Regain Compliance with Listing Rules

    New York, NY, Sept. 13, 2024 (GLOBE NEWSWIRE) -- NorthView Acquisition Corporation. (NASDAQ:NVAC) (the "Company") announced that it has received a notice (the "Notice") from The Nasdaq Stock Market LLC ("Nasdaq") granting the Company an exception to regain compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the "SEC"). Pursuant to the terms of the exception, the Company must file its Quarterly Reports on Form 10-Q for the periods ending March 31, 2024 and June 30, 2024 on or prior to October 14, 2024. If the Company does not satisfy the terms of the exception, the

    9/13/24 4:30:00 PM ET
    $NVAC
    Medical/Dental Instruments
    Health Care

    $NVAC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by NorthView Acquisition Corporation

    SC 13G - NorthView Acquisition Corp (0001859807) (Subject)

    3/27/24 6:05:55 AM ET
    $NVAC
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by NorthView Acquisition Corporation (Amendment)

    SC 13G/A - NorthView Acquisition Corp (0001859807) (Subject)

    2/22/24 9:05:41 AM ET
    $NVAC
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by NorthView Acquisition Corporation (Amendment)

    SC 13G/A - NorthView Acquisition Corp (0001859807) (Subject)

    2/14/24 4:53:53 PM ET
    $NVAC
    Medical/Dental Instruments
    Health Care